A government official says that the first volunteer will receive the first experimental dose.
The National Institutes of Health is funding the trial taking place at a Kaiser Permanente facility in Seattle. The testing will begin with 45 young, healthy volunteers with different doses of shots co-developed between the NIH and Moderna, Inc.
While this is promising news, it is important to note that officials say it will take 12-18 months to fully validate the vaccine as effective and safe to use. However, it is still an important step forward, and while a vaccine may be a ways away, hopefully this research can further help the development of treatment for the virus.
For all your coronavirus news and more, be sure to check back in here at ScoopHash.